NEWS
Industry News
Are CBD skincare products effective?
Cannabidiol (CBD), one of 113 identified cannabanoids, has known anti-inflammatory and pain-relieving properties. In dermatology, a variety of topical products are becoming increasingly available to patients; however, much work remains to create CBD-containing dermatology products that can effectively treat skin disorders, one expert says.
Read Article »Are CBD skincare products effective? (Dermatology Times)
Cannabidiol (CBD), one of 113 identified cannabanoids, has known anti-inflammatory and pain-relieving properties. In dermatology, a variety of topical products are becoming increasingly available to patients; however, much work remains to create CBD-containing dermatology products that can effectively treat skin disorders, one expert says.
Read Article »The Therapeutic Potential of Cannabinoids in Dermatology
Cannabinoids have demonstrated utility in the management of cancer, obesity, and neurologic disease. More recently, their immunosuppressive and anti-inflammatory properties have been identified for the treatment of several dermatologic conditions.
Read Article »The CBD Gold rush has begun
CBD, the chemical found in hemp and marijuana plants, is showing up in shampoos, lattes, body oils, gummy bears and dog treats.
Read Article »The wide-ranging potential of cannabinoids
The wide-ranging potential of cannabinoids to treat a variety of cancerous tumors and certain immunological and neoplastic diseases in a Dermatology Times article by Lissette Hilton.
Read Article »Dermatology World Meeting News at the AAD Meeting
Dermatology World Meeting News at the AAD Meeting to discuss some of the recent advances in treating tumors and inflammatory skin diseases and what could be coming next, including the potential of cannabinoids to treat various diseases and conditions
Read Article »Adam Friedman MD is interviewed by Health.com
Adam Friedman MD is interviewed by Health.com about possible skin-related benefits of CBD in an online article titled, “Do Cannabis-Infused Beauty Products Actually Work? Everything You Need to Know” by Lisa Desantis
Read Article »Beauty Not As Pain, But A Remedy For It
Adam Friedman MD weighs in on the pros and cons of using cannabis in skin cremes to relieve pain in the article, “Beauty Not As Pain, But A Remedy For It” in the BENEATH THE SURFACE section of BeautyIndependent
Read Article »Greenway News
Greenway Therapeutix CEO, Dr. Milane, recently featured in the Dermatology Digest
Greenway Therapeutix’s CEO, Dr. Michael Milane and CSO, Dr. Dan Siegel, were recently interviewed by the Dermatology Times about the potential of Cannabinoid therapeutics in Dermatology for various inflammatory conditions.
Read Article »Greenway Therapeutix® is Exhibiting at the Generational Dermatology Meeting
Greenway Therapeutix’s CEO, Dr. Michael Milane and CSO, Dr. Dan Siegel, were recently interviewed by the Dermatology Times about the potential of Cannabinoid therapeutics in Dermatology for various inflammatory conditions.
Read Article »Greenway Therapeutix® is Exhibiting at the Prestigious Maui Derm Meeting
Greenway Therapeutix’s CEO, Dr. Michael Milane and CSO, Dr. Dan Siegel, were recently interviewed by the Dermatology Times about the potential of Cannabinoid therapeutics in Dermatology for various inflammatory conditions.
Read Article »Greenway Therapeutix Leadership, recently interviewed by Dermatology Times on the potential of Cannabinoids in Dermatology
Greenway Therapeutix’s CEO, Dr. Michael Milane and CSO, Dr. Dan Siegel, were recently interviewed by the Dermatology Times about the potential of Cannabinoid therapeutics in Dermatology for various inflammatory conditions.
Read Article »Greenway Therapeutix CEO, Dr. Michael Milane presents at the 2019 Autumn Dermatology Conference
Greenway Therapeutix CEO, Dr. Michael Milane presents at the 2019 Autumn Dermatology Conference New York, NY, November 04, 2019 – Greenway Therapeutix, Inc., a Biopharmaceutical company dedicated to the research and development of medical grade cannabinoid therapeutics utilizing nanotechnology, was at the 2019 Autumn Dermatology Conference in New York. The company’s CEO, Dr. Michael Milane, […]
Read Article »Greenway Therapeutix CEO, Dr. Michael Milane presents at the 2019 Practical Symposium
Greenway Therapeutix CEO, Dr. Michael Milane presents at the 2019 Practical Symposium Beaver Creek, CO, August 09, 2019 – Greenway Therapeutix, Inc., a Biopharmaceutical company dedicated to the research and development of medical grade cannabinoid therapeutics utilizing nanotechnology, was at the 2019 Practical Symposium in Beaver Creek, Colorado. The company’s CEO, Dr. Michael Milane, presented […]
Read Article »